Literature DB >> 1655531

Differential glycosylation of N-POMC1-77 regulates the production of gamma 3-MSH by purified pro-opiomelanocortin converting enzyme. A possible mechanism for tissue-specific processing.

N P Birch1, F E Estivariz, H P Bennett, Y P Loh.   

Abstract

The amino terminus of bovine pro-opiomelanocortin (N-POMC1-77) is partially processed in the intermediate lobe of the pituitary to N-POMC1-49 and lys-gamma 3-melanotropin. Two pools of N-POMC1-77 were isolated which were differentially glycosylated at threonine45, while N-POMC1-49 isolated from bovine intermediate lobe extracts existed in a non-glycosylated form. This suggested that differential O-linked glycosylation of N-POMC1-77 may regulate cleavage at the Arg49-Lys50 processing site. We tested this hypothesis by incubating N-POMC1-77 glycoforms with purified proopiomelanocortin converting enzyme. Only non-O-glycosylated N-POMC1-77 and O-glycosylated N-POMC1-77 with truncated oligosaccharide sidechains were sensitive to cleavage and generated predominantly lys-gamma 3-melanotropin, identified by high-performance liquid chromatography. These data provide the first functional evidence to support a role for differential O-linked glycosylation in the regulation of the processing of the N-terminus of bovine POMC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655531     DOI: 10.1016/0014-5793(91)81257-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing.

Authors:  Katrine Ter-Borch Gram Schjoldager; Malene B Vester-Christensen; Christoffer K Goth; Thomas Nordahl Petersen; Søren Brunak; Eric P Bennett; Steven B Levery; Henrik Clausen
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  TAILS N-terminomics and proteomics reveal complex regulation of proteolytic cleavage by O-glycosylation.

Authors:  Sarah L King; Christoffer K Goth; Ulrich Eckhard; Hiren J Joshi; Amalie D Haue; Sergey Y Vakhrushev; Katrine T Schjoldager; Christopher M Overall; Hans H Wandall
Journal:  J Biol Chem       Date:  2018-03-28       Impact factor: 5.157

3.  Bilateral adrenal enucleation-induced changes in adenohypophyseal pro-opiomelanocortin (POMC)-related peptides synthesis and secretion: a comparative study with adrenalectomized rats.

Authors:  M J Perone; A N Chisari; C L Gómez Dumm; E Spinedi; F E Estivariz
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

Review 4.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  Mucin-Type O-GalNAc Glycosylation in Health and Disease.

Authors:  Ieva Bagdonaite; Emil M H Pallesen; Mathias I Nielsen; Eric P Bennett; Hans H Wandall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

6.  Engineering of mucin-type human glycoproteins in yeast cells.

Authors:  Koh Amano; Yasunori Chiba; Yoshiko Kasahara; Yukinari Kato; Mika Kato Kaneko; Atsushi Kuno; Hiromi Ito; Kazuo Kobayashi; Jun Hirabayashi; Yoshifumi Jigami; Hisashi Narimatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

7.  Quantitative mass spectrometry for human melanocortin peptides in vitro and in vivo suggests prominent roles for β-MSH and desacetyl α-MSH in energy homeostasis.

Authors:  Peter Kirwan; Richard G Kay; Bas Brouwers; Vicente Herranz-Pérez; Magdalena Jura; Pierre Larraufie; Julie Jerber; Jason Pembroke; Theresa Bartels; Anne White; Fiona M Gribble; Frank Reimann; I Sadaf Farooqi; Stephen O'Rahilly; Florian T Merkle
Journal:  Mol Metab       Date:  2018-08-21       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.